II. Definitions
A. PHARMACOLOGY: how chemical substances interact with living
systems; subdivisions include
1. PHARMACOGNOSY: "weeds and seeds"
This was the original basis of pharmacy,
and, for that matter, of medicine ("pharm" meaning drugs and "gnosis" meaning
knowledge); while it has fallen out of favor over the past generation,
it is re-emerging as a legitimate discipline as people seek alternative
routes for their health care. These lectures shall introduce such
herbal therapies as they are appropriate to the subject.
2. PHARMACY: compounding and dispensing "lick and stick"
3. TOXICOLOGY: adverse effects, poisoning
4. PHARMACOKINETICS: factors affecting concentration of a drug
in the body or at its site of action
5. PHARMACODYNAMICS: biological effects of a drug and the mechanism
that produces these effects (the main thrust of these lectures)
6. PHARMACOTHERAPEUTICS: how drugs prevent, control, or cure
diseases
B. Pharmacodynamic effects may be achieved by:
1. stimulating or blocking
the effect of chemicals already in the body
2. directly stimulating
or depressing cellular function
3. exerting purely physical
actions on the body
4. replacing or augmenting
actual body chemicals
5. destroying parasites
(tapeworms, amoeba, etc)
III. ADME
"ABSORPTION--DISTRIBUTION--METABOLISM--EXCRETION"
A. Absorption
1. movement
of drug from the site of administration to the bloodstream
2. affected
by
a. route of administration
b. blood flow to area of administration
c. physical state of drug
3. Routes of
administration
a. enteral-- means the use of the GI tract; the most common route
i. oral, sublingual (abbreviated “SL”), rectal
–advantages
(a) ease of administration
(b) sterility not necessarily an issue (you've put worse things in your
mouth)
(c) once introduced, can be purged or flushed if necessary
--disadvantages
(a) GI irritation (aspirin)
(b) food interactions (tetracycline and calcium)
(c) destruction of drug (insulin is not effective orally)
(d) absorption usually slow (except sublingually)
b. parenteral– means introducing the drug to the body by non-enteral means
IM (intramuscular), IV (intravenous), SC (sub-cutaneous; sometimes abbreviated
“SQ”), intrathecal, intra-arterial
--more rapid onset, but also
--greater onset of side effects
--irritation at injection site
--increased avenue for infection
–-also, once a drug enters the bloodstream, it is very hard to remove!
c. inhalation
--anesthesia, respiratory drugs for asthma
– inhalation antivirals for influenza therapy (Relenza)
d. via mucous membranes
--eye, nose, throat, vagina, bladder
--localized effect, but systemic absorption possible
(blood pressures have been altered from long-term use of beta blockers
to treat glaucoma or nasal sprays used to
treat congestion)
e. skin
--toxins may be absorbed via this route (insecticides "DDT", "agent orange"
and chemicals such as carbon tetrachloride...and mercury to cure leather...the
source of the madness of a "Mad Hatter")
--therapeutically, some drugs are administered as topical patches:
CAPSCACIN ("Mustard plasters"): for muscle aches
SCOPOLAMINE (Transderm-Scop): for nausea
NITROGLYCERIN (Transderm Nitro, Nitro-Derm): for angina
CLONIDINE (Catapres TTS): for hypertension
ESTROGEN (Estraderm): for menopausal syndromes
FENTANYL (Duragesic): for pain
NICOTINE (Nicoderm, Habitrol): for nicotine withdrawal
TESTOSTERONE (Androderm): for hypogonadal conditions
LIDOCAINE (Dentipatch): topal anesthesia for dental procedures
4. Bioavailability-- "The amount and rate of entrance of a drug
into the circulation"
a. factors affecting bioavailability
i. rate of absorption; administration site
ii. lipid solubility--where it may be stored in the body
iii. physical state of drug has an effect
--compare tablets vs capsules vs solutions vs enteric coatings; "depo"
administration of lipid soluble agents
b. in a situation where you have two tablets containing the same drug,
the higher strength tablet is more bioavailable. For example:
Ibuprofen (Motrin) 800mg is more bioavailable than ibuprofen
200mg
c. Sometimes a drug company will use the relatively simple term bioavailability
as a marketing method, implying “more is better.” For example, for
many years a combination product of hydrochlorthiazide and triamterene
called Dyazide was available to treat hypertension. Another company
came along, took the same two ingredients but increased the amount by 50%
and called their product Maxzide. They then heavily marketed their
product as being “more bioavailable.” It worked. It is something
akin to saying “two apples are more bioavailable than one apple.”
CAVEAT EMPTOR!
--remember that most doctors get their drug information not from college
training in pharmacology, but from drug reps...and that's more marketing
than medicine
B. DISTRIBUTION
--The drug goes for its site of action
via the bloodstream
1. Factors that
can hold up distribution
a. binding to plasma proteins
ALBUMIN is the major plasma protein
--consider two drugs battling it out for the same plasma protein site--
warfarin and aspirin, for example
b. storage in body fat
c. other sites where material/drugs can accumulate
LIVER--quinacrine (anti-malarial drug)
BONE AND TEETH--tetracycline (antibiotic), lead (from paint, water, pollution)
IV. OTHER CONSIDERATIONS
A. BLOOD BRAIN BARRIER
1. meninges are of
high lipid concentration
2. lipid soluble drugs
can pass
--anethetics, antiepileptics
3. water soluble drugs
are effectively blocked
B. CROSSING THE PLACENTA
1. placental barrier is of limited effectiveness, and there is no guarantee
that agents in the mother's blood will not reach the fetus
2. first trimester generalization--since there are no real studies showing
that anything is particularly safe during the first three months of gestation,
the general rule is to be leery of any drug during this time
C. Breast milk crossovers
1. Several factors
a. fat content (lipid solubility)
breast milk is 2-3% fat
b. protein bound drugs less likely to pass
c. large size drug molecules less likely to pass
d. weakly acidic drugs less likely to concentrate in breast milk (milk
pH is 6.7 to 7.4)
2. Drugs involved
a. antibiotics
i. penicillins/cephalosporins
both safe for the nursing child
ii. tetracycline/erythromycin
should also be safe; evidently not enough tetracycline
passes through the milk to be of concern
--biggest possible side effect is loss of child's normal
body flora even at the minute amounts digested, resulting in diarrhea
b. asthmatic drugs
i. theophyllines should be sustained release preparations--child
can develop symptoms otherwise
c. anticoagulants
i. warfarin appears safe (high protein binding)
ii. heparin appears safe (large molecule size)
d. antihypertensives
i. thiazide diuretics--may decrease lactation
ii. beta blockers--may cause beta-blocking effects in the child
e. antiepileptics
i. phenobarbital will be passed on to the child (high lipid solubility)
ii. phenytoin, carbamazepine, ethosuccimide will be passed on as well
iii. valproic acid does not enter breast milk
f. thyroid products
i. thyroid will pass in small amounts, but is considered safe
g. narcotics will pass into breast milk--
morphine and codeine are particularly likely to cause
problems; meperidine is less likely, but child should still be monitored
for sedation
1. discuss the interrelationship between dose and
potency
2. identify an enzyme by its suffix
3. compare synergism with antagonism
4. discuss the differences between a broad and
a narrow therapeutic index
5. list examples of antagonists
6. to define agonist, affinity, and intrinsic activity
7. define enzyme induction and give an example
of a drug that can cause the condition.
8. give examples of products that are astringents
9. identify another name for the 8th cranial nerve
and discuss what damage to it can cause
Consider a case study: if one tablet is good, isn't two always better? Also, if you have 300mg of one drug, is it stronger than 0.25mg of another drug?
Example #1: aspirin
usual strengths: 81mg, 325mg, 500mg
Example #2: digoxin (Lanoxin)
usual strengths: 0.125mg, 0.25mg, 0.5mg
I. A matter of terms
A. Drug Activity: what happens when a drug reacts with a responsive
site
1. specific sites
a. cell receptors
b. enzymes
--Definition of enzyme: a compound that can make changes
in another substance without changing itself; a catalyst
--"ASE" suffix on all enzymes (with the exception of “renin”,
enzymes, or substances that cause breakdown of chemicals that pass through
the liver or other areas of the body, have the same suffix-- penicillinase,
acetylcholinesterase, etc.)
2. generalized activity (anesthesia)
3. mechanical (antacids,
sunblocking agents)
B. Receptor Sites
1. Jigsaw puzzle concept
"the drug fits!"
specific drug-to-receptor complex
"opiate" receptors and pain
2. Blocking the effect
--a drug binds but does not produce an effect– antagonism
--naloxone (Narcan)--pure narcotic agonist
use: to reverse the effects of an opiate analgesic
--naltrexone (reVia)
use: to control the symptoms of alcohol withdrawal
C. Affinity and Intrinsic activity
1. Affinity:
--degree of attraction between a ____drug__________ and its___receptor
site________
2. Intrinsic activity:
if the drug-receptor complex produces an action
D. Agonists combine the affinity with an intrinsic activity
E. Antagonists, therefore...
have affinity for a receptor but do not possess intrinsic
activity
F. Agonist/antagonist properties: partial agonists that initially
stimulate, then block
--nicotine is an example
nicotine stimulates cholinergic receptors that are nicotine-specific;
once on-site, the nicotine then blocks the receptors and further stimulation
is no longer possible at that site. The body eventually creates more
nicotine-specific receptors, requiring more of the drug to get the same
effect. Open receptors send out signals for more drug in the form
of withdrawal symptoms (usually within 20 minutes of the last delivery
of drug) which escalate with the number of receptor sites. A "refreshing
smoke" is merely a relief of the withdrawal symptoms, a cycle which can
repeat indefinitely until the user chooses to quit by choice or by death.
End of sermon.
II. Drugs and Enzyme Induction: a drug's effect on the liver
What is enzyme induction? The stimulation of enzyme
production that results in increased hepatic metabolism
An example of a drug that can cause enzyme induction: phenobarbital
What is the primary use of this drug? to treat epilepsy
III. Mechanical and Chemical Activity
A. Localized activity
B. many are OTC (over-the-counter)
1. adsorbents
--kaolin, pectin, activated charcoal
2. laxatives
a. bulk (psyllium colloid [Metamucil, Citrucel, et al])
must have a lot of added fluid as part of the therapy
b.
saline--magnesium citrate or "purgative lemonade"
this product, like revenge, is best when served: cold
c. stimulant--cascara (from the Cascara sagrada plant) or senna (from the
senna plant)
a favorite addition to "diet herb teas"
d.
emoillent--docusate (Colace)
literally, you are adding soap to the system (taste the liquid version
sometime, eeuh)
3. antacids--chemical neutralization
--antacids are weak bases (magnesium HYDROXIDE, aluminum HYDROXIDE)
to act as chemical neutralizers, or act as weak buffers, such as calcium
carbonate
Note: these antacids differ both in chemical composition
and mechanism of action from the class of antacids known as the "H-2 antagonists"
or "proton pump inhibitors." These other classes will be discussed
later.
V. DOSAGE, POTENCY, EFFICACY
A. DOSING
1. determination of dose
a. ADME (absorption-distribution-metabolism-excretion) characteristics
b. LD50 or TD50
LD means: “lethal dose” The # refers to the % of
the test population affected (ie LD 50 indicates that 50% of the test population
died with that specific dose)
TD means: “toxic dose”
c. clinical studies-- not required until the early 1960s after the disaster with Thalidomide
B. POTENCY: relative to dosage
C. EFFICACY
--relates only to ability of drug to produce desired response
--consider aspirin and dental pain vs aspirin and pain of bone
cancer
VI. Factors affecting drug activity
A. Drug Interactions
1. Enhancement
--potentiation SYNERGISM
"one plus one equals three" (two antibiotics working together
can sometimes have a greater spectrum of activity than either one working
alone)
i.e., Tobramycin (an aminoglycoside antibiotic) and carbenicillin
(penicillin)
Another example is where one drug inhibits the metabolism
of another, resulting in increased drug levels. Ciprofloxacin (Cipro),
a quinolone antibiotic, can inhibit the metabolism of caffeine. Coffee
drinkers taking Cipro have often experienced tachycardia!
c.
kinetic antagonism
--hepatic enzyme induction and increased metabolism
--drugs that can stimulate or inhibit the other enzyme
pathways in the liver
B. Drug-Food Interactions
1. griseofulvin (an
antifungal drug) and greasy foods:
absorption is improved
2. tetracycline and
dairy products:
absorption of tetracycline is diminished; chelates are formed
with Calcium, Aluminum, Magnesium, Lithium, and Iron
3. MAO (monoamine
oxidase) inhibitors
(used to treat depression or Parkinsonism--Parnate and Marplan
are examples) and aged cheese or beer (foods high in the amino acid tyramine
or tryptophan); even avocados and bananas
C. Accumulation and Tolerance
1. accumulation and
sustained release
--lipid partitioning
--fat-soluble vitamins A-D-E-K
mainly a concern with toxicity
I. Vitamin A–Patient information
A. “Avoid prolonged use of mineral oil and
cholestyramine (Questran, a cholesterol-lowering agent) while taking this
drug. Do not exceed recommended dosage. Notify your physician
if nausea, vomiting, anorexia, malaise, dry or cracking skin or lips, irritability
or hair loss occur. These are symptoms of toxicity.”
B. Beta-carotene (15mg = 25,000 IU of vitamin A)
1. do not take with dairy products
2. skin may appear slightly yellow-orange while on this therapy
3. beta-carotene is a precursor to vitamin A and a naturally
occurring pigment in dark green and yellow-orange vegetables
4. a controversial role in lowering the incidence of cardiovascular
disease and cancer, particularly lung cancer
5. fat in the diet serves as a carrier for beta-carotene; low-fat
diets will result in reduced absorption of beta-carotene
II. Vitamin D (“dihydrotachysterol or DHT” or “Hytakerol”)
A. Patient information
“Not to be considered an alternative to a healthy diet.
Signs of toxicity include weakness, lethargy, headache, anorexia, weight
loss, nausea, vomiting, abdominal cramps, diarrhea or constipation, vertigo,
excessive thirst, excessive urine output, dry mouth, muscle or bone pain.”
B. General information
1. Vitamin D is considered a hormone.
2. Vitamin D metabolites promote active absorption of calcium
and phosphorus in the small intestine and promote reabsorption of calcium
and phosphorus in the kidneys.
3. Vitamin D is involved in magnesium metabolism.
C. Deficiency
1. deficiencies lead to progressive hearing loss, rickets in
children, and osteomalacia in adults
2. often referred to as the “sunshine vitamin” since it is synthesized
in the skin through a reaction involving sunlight and cholesterol
D. Drug Interactions
1. digitalis (Lanoxin): increased calcium levels with vitamin
D can cause heartbeat irregularities
2. mineral oil, cholestyramine (Questran), phenytoin (Dilantin),
and phenobarbital can caused reduced blood levels of vitamin D, either
through blocking its absorption or promoting its metabolism and excretion.
III. Vitamin E
A. Patient information
“Swallow capsules whole, do not crush or chew. Use cautiously
with other anticoagulant drugs (ie, Coumadin or Plavix), since the effects
of anticoagulant drugs may be enhanced, with potential bleeding occurring.”
B. General information
1. Vitamin E has been used as an adjunct treatment (primarily
for its antioxidant properties) in cancer, skin conditions, heart disease,
sexual dysfunction, aging, PMS, and to enhance athletic performance.
Studies currently indicate that vitamin E may be effective in delaying
onset of symptoms of Alzheimer’s disease.
2. the RDA is 15 units/day. Usual doses, however, for
the above activities are generally 400 units up to three times a day.
IV. Vitamin K
A. Patient information
“Avoid prolonged use of mineral oil, since mineral oil can decrease
the absorption of vitamin K. Anticoagulant drugs such as Coumadin
or Plavix may be antagonized by concurrent use of vitamin K.”
B. General information
1. synthesized in the intestine by bacteria; in addition, vitamin
K can be found in the following foods:
–cabbage, cauliflower, kale, spinach, fish, liver, eggs,
meats, cereal grain products, fruits, and milk and dairy products
2. Vitamin K, while it interferes with Coumadin, does not interact
with heparin; Coumadin and heparin cause their effects on clotting by different
mechanisms
3. supplemental doses are usually given by injection, although
a 5mg tablet is available
Protracted (ie “prolonged”) use of sulfa drugs may produce symptoms
of vitamin K deficiency because sulfa drugs
a. are detoxified in the liver
b. combine chemically with vitamin K
c. inhibit growth of intestinal flora (bacteria)
d. interfere with the conversion of prothrombin to thrombin
e. inhibit calcium absorption which is essential to enzyme systems
This argument can be used for ANY antibiotic, by the way. If
you are killing off pathogenic invaders of the human body, you generally
run the risk of killing off the body’s natural “flora” along the way.
This “flora” is responsible for manufacturing most of the vitamin K that
the body has, and it is mainly produced in the large intestine. By
the way, dead bacteria swell up in the colon, and since gravity is the
LAW, they have no where to go but OUT, taking copious fluids with them.
This is the post-therapy diarrhea that many patients complain about when
taking an antibiotic.IV. Vitamin K (phytonadione “Mephyton”)
D. Individual variations
1. Genetics
2. Weight
3. Age
a. hepatic immaturity in children
--use of Ritalin for hyperkinesis (usually Ritalin
or methylphenidate is considered a stimulant)
b. elderly patients and decreased absorption
4. Disease state
5. Placebo effect
The placebo effect has been getting more publicity of
late; studies (November, 1995; Boston seminar on psychic healing) are showing
higher than expected (60-90%) effectiveness rates of treating conditions
such as hypertension and stress using placebo or "alternative" therapies
vs the standard drug regimens
Precautions must be taken when drugs are given to geriatric patients
because elderly people
a. may metabolize drugs less rapidly
b. may not be able to excrete drugs as rapidly
c. will usually require greater than average adult doses
d. all of the above
The elderly population is hit with a double dose of bad luck, physiologically
speaking– (1) their livers are not producing the same amount of metabolic
enzymes as before, thereby slowing the rate of drug metabolism. Therefore,
drug levels rise. Also, (2) their renal system is slower, thereby
reducing the rate of elimination of drugs and their active metabolites
once the liver has finished with them... thus, the drug hangs out longer
in the body.
If a patient develops tolerance to a drug, that means he has
a. had an unexpected side effect
b. obtained maximum response to the drug
c. a need for an increase in dose to produce the usual
effect of the drug
3. Excretion
a. Kidneys
i. filtration
ii. reabsorption
--nutrients and electrolytes are preserved
iii. secretion
--active transport
--penicillin (or ampicllin) and probenecid: given
together to prevent excretion of the penicillin, increasing its duration
of action, a "one dose" oral therapy for gonorrhea
b. GI
i. liver and bile
ii. lungs and paraldehyde
(alcohols,aldehydes and ketones--consider diabetics
in ketoacidosis--ketones are exhaled with a resulting "fruity" breath)
B. Adverse Reactions
1. also "side effects,"
"toxic effects"
2. concern lasting damage
to the body
--liver,
kidney, bone marrow, 8th cranial nerve
8th cranial nerve is also known as the AUDITORY nerve
damage to this nerve can cause: DEAFNESS
3. adverse reactions
may be
a. dose dependent
b. dose independent--allergic reactions
c. interchangeable with therapeutic effect
--atropine and diminished salivation (an anticholinergic effect)
--disulfram (Antabuse) reaction and nausea
C. Therapeutic Index
1. relationship between
toxicity and effectiveness
2. narrow: great care to prevent
toxicity
3. broad: generally safe
over a wide dosing range
End of Module One
Comments: Jim Middleton, Pharmacist
and Instructor
KCC Pharmacology for Dental Hygienists